Friday, October 07, 2022 3:24:09 PM
Recent BHVN News
- Biohaven Achieves Positive Topline Results in Pivotal Study of Troriluzole in Spinocerebellar Ataxia (SCA) • PR Newswire (US) • 09/23/2024 11:30:00 AM
- Biohaven Announces Conference Call to Discuss Topline Pivotal Study Results in Spinocerebellar Ataxia • PR Newswire (US) • 09/20/2024 11:09:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/16/2024 08:35:34 PM
- Form 424B7 - Prospectus [Rule 424(b)(7)] • Edgar (US Regulatory) • 08/16/2024 08:31:59 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/16/2024 08:25:28 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 08/16/2024 08:21:04 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2024 08:06:46 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/08/2024 08:17:54 PM
- Biohaven Reports Second Quarter 2024 Financial Results and Recent Business Developments • PR Newswire (US) • 08/08/2024 08:05:00 PM
- Biohaven Showcases Broad Innovative Portfolio and Pipeline Updates Across Multiple Therapeutic Areas including Immunology, Neuroscience, Metabolic Disorders and Oncology at Annual Investor R&D Day • PR Newswire (US) • 05/29/2024 11:30:00 AM
- Biohaven Doses First Patient with its Novel Trop-2 Directed Antibody Drug Conjugate (ADC) BHV-1510 in Advanced or Metastatic Epithelial Tumors • PR Newswire (US) • 05/29/2024 11:15:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/17/2024 08:42:44 PM
- Form 424B7 - Prospectus [Rule 424(b)(7)] • Edgar (US Regulatory) • 05/17/2024 08:41:07 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 05/09/2024 08:16:50 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/09/2024 08:14:14 PM
- Biohaven Reports First Quarter 2024 Financial Results and Recent Business Developments • PR Newswire (US) • 05/09/2024 08:05:00 PM
- Biohaven Announces Closing of Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares • PR Newswire (US) • 04/22/2024 08:05:00 PM
- Biohaven Announces Proposed Public Offering of Common Shares • PR Newswire (US) • 04/17/2024 08:05:00 PM
- Biohaven Showcases Innovative Neuroscience Portfolio with 20 Presentations at the 2024 American Academy of Neurology (AAN) Annual Meeting and Provides Other Business Updates • PR Newswire (US) • 04/13/2024 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/29/2024 09:16:45 PM
- Biohaven Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Developments • PR Newswire (US) • 02/29/2024 09:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/08/2024 12:30:54 PM
- Biohaven Highlights Progress Across Innovative Portfolio and Outlines 2024 Anticipated Milestones at the 42nd Annual J.P. Morgan Healthcare Conference; Established Extensive Portfolio Across 20 Therapeutic Indications in Neuroscience, Immunology and Oncolo • PR Newswire (US) • 01/08/2024 12:30:00 PM
- Biohaven to Present at the 42nd Annual J.P. Morgan Healthcare Conference • PR Newswire (US) • 01/02/2024 12:00:00 PM
- Biohaven Presents Expanded EEG and Safety Data for BHV-7000 at the American Epilepsy Society Annual Meeting • PR Newswire (US) • 12/01/2023 09:30:00 PM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM